-
US and Ukraine draft new 19-point peace plan but defer biggest decisions
The most politically sensitive elements left for Trump and Zelenskyy to discuss
-
Chinese exporters charge Russia more for war supplies as sanctions bite
Price increases show that western restrictions are limiting Moscow’s capabilities, Bank of Finland research finds
-
Bayer soars on promising trial results for stroke prevention drug
Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal
-
UK life insurers clear stress tests as private capital influx raises concerns
Sector deemed resilient even as a wave of investment raises fears over future vulnerability
-
Novo Nordisk shares slump after drug failure in Alzheimer’s trial
Outcome is blow to one of Europe’s largest listed companies
-
The Trump team’s tortured path to a Ukraine peace plan
Washington’s mixed signals and shifting proposals unsettle allies as negotiations near a critical phase
-
‘Keir Starmer is not on the ballot paper in this election’, says Welsh first minister
Labour’s Eluned Morgan distances herself from national government ahead of Senedd ballot in May
-
What big bond investors want from the UK Budget
Gilt market players call on government to cut spending and steer clear of inflationary tax




